Apaxen

Developer of small molecules for treating pulmonary diseases

placeCharleroi, Wallonia, Belgium calendar_todayFounded 2018 groups4 employees language apaxen.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace slowing. Cited 1 times.

YearFilings
20211

Investor mix

3 investors on record; lead investors include Theodorus.

Investor typeCountShare
Venture capital267%
Private equity133%
Coming soon